OBR Daily Commentary


Veru's Experimental Drug Reduces Hot Flashes In Men In Mid-Stage Study

(Reuters) Jan 13, 2020 - Veru Inc said on Monday a higher dose of its experimental drug reduced hot flashes in men with advanced prostate cancer after six weeks of treatment, in a mid-stage study.

Read Article arrow

Tomasz M. Beer, MD, FACP (Posted: January 13, 2020)


Hot flashes are a common consequence of hormonal therapy for prostate cancer and strategies to treat them are important for quality of survivorship. It is not surprising that an estrogenic drug would be effective. It will be important to learn more about any side effects that might emerge with additional studies.



Add Comment 1 Comment(s)